BACKGROUND: Gastric carcinoid tumors occur in 15% to 50% of patients with multiple
endocrine neoplasia–1/Zollinger-Ellison syndrome (MEN-1/ZES) but are thought to be …

Treatment of the Zollinger-Ellison syndrome (ZES) in patients with multiple endocrine
neoplasia type I (MEN I) is controversial. Unlike other patients with ZES who have a single …

Background and Methods The role of surgery in patients with the Zollinger–Ellison
syndrome is controversial. To determine the efficacy of surgery in patients with this …

Abstract Introduction Pancreatic endocrine tumors (PETs) occur in at least 50% of patients
with multiple endocrine neoplasia type 1 (MEN1) and are the leading cause of disease …

Mignon M, Cadiot G (Bichat and Claude Bernard Hospital, Paris, France). Diagnostic and
therapeutic criteria in patients with Zollinger–Ellison syndrome and multiple endocrine …

Background. The management of pancreaticoduodenal endocrine tumors (PETs) remains
controversial in multiple endocrine neoplasia type 1 (MEN 1). Methods. Twenty-one patients …

Abstract purpose: To determine whether patients with multiple endocrine neoplasia type I
(MEN-I) can initially present with Zollinger-Ellison syndrome (ZES), and to learn whether …

The clinical evolution of type I multiple endocrine neoplasia (MEN I) was studied in 45
patients among a consecutive series of 172 with Zollinger-Ellison syndrome (ZES). These …

AIM: To search for the optimal surgery for gastrinoma and duodenopancreatic
neuroendocrine tumors in patients with multiple endocrine neoplasia type 1. METHODS …

Objective To determine the clinical features, natural history, and role of surgery for
gastrointestinal manifestations of the multiple endocrine neoplasia type 2 (MEN 2) …